Investor Relations
Welcome to Alzinova AB’s IR pages.
Alzinova AB is a company specializing in the treatment of Alzheimer’s disease – one of our major health scourges, without effective treatment options.
Latest press releases
- 2022-06-15 | Regulatory Alzinova announces outcome of rights issue
- 2022-06-08 | Regulatory Alzinova appoints Mangold Fondkommission as new liquidity provider
Latest news
- 2022-06-27 New Analysis Report from Redeye
- 2022-06-13 Professor Henrik Zetterberg talks about his collaboration with Alzinova